Cell-autonomous regulation of complement C3 by factor H limits macrophage efferocytosis and exacerbates atherosclerosis

Complement factor H (CFH) negatively regulates consumption of complement component 3 (C3), thereby restricting complement activation. Genetic variants in CFH predispose to chronic inflammatory disease. Here, we examined the impact of CFH on atherosclerosis development. In a mouse model of atheroscle...

Full description

Saved in:
Bibliographic Details
Published in:Immunity (Cambridge, Mass.) Mass.), 2023-08, Vol.56 (8), p.1809-1824.e10
Main Authors: Kiss, Máté G, Papac-Miličević, Nikolina, Porsch, Florentina, Tsiantoulas, Dimitrios, Hendrikx, Tim, Takaoka, Minoru, Dinh, Huy Q, Narzt, Marie-Sophie, Göderle, Laura, Ozsvár-Kozma, Mária, Schuster, Michael, Fortelny, Nikolaus, Hladik, Anastasiya, Knapp, Sylvia, Gruber, Florian, Pickering, Matthew C, Bock, Christoph, Swirski, Filip K, Ley, Klaus, Zernecke, Alma, Cochain, Clément, Kemper, Claudia, Mallat, Ziad, Binder, Christoph J
Format: Article
Language:English
Subjects:
Animals
Atherosclerosis - metabolism
Complement C3 - genetics
Complement C3 - metabolism
Complement Factor H - genetics
Complement Factor H - metabolism
Humans
Inflammation
Macrophages - metabolism
Mice
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Complement factor H (CFH) negatively regulates consumption of complement component 3 (C3), thereby restricting complement activation. Genetic variants in CFH predispose to chronic inflammatory disease. Here, we examined the impact of CFH on atherosclerosis development. In a mouse model of atherosclerosis, CFH deficiency limited plaque necrosis in a C3-dependent manner. Deletion of CFH in monocyte-derived inflammatory macrophages propagated uncontrolled cell-autonomous C3 consumption without downstream C5 activation and heightened efferocytotic capacity. Among leukocytes, Cfh expression was restricted to monocytes and macrophages, increased during inflammation, and coincided with the accumulation of intracellular C3. Macrophage-derived CFH was sufficient to dampen resolution of inflammation, and hematopoietic deletion of CFH in atherosclerosis-prone mice promoted lesional efferocytosis and reduced plaque size. Furthermore, we identified monocyte-derived inflammatory macrophages expressing C3 and CFH in human atherosclerotic plaques. Our findings reveal a regulatory axis wherein CFH controls intracellular C3 levels of macrophages in a cell-autonomous manner, evidencing the importance of on-site complement regulation in the pathogenesis of inflammatory diseases.
ISSN:1074-7613
1097-4180
1097-4180
DOI:10.1016/j.immuni.2023.06.026